⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MAIA News
MAIA Biotechnology, Inc.
Form 8-K
sec.gov
MAIA
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
globenewswire.com
MAIA
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
globenewswire.com
MAIA
MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
MAIA
Form 8-K
sec.gov
MAIA
MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
globenewswire.com
MAIA
MAIA Pharmaceuticals Selected by Asahi Kasei Pharma to Advance Teribone™ for US Osteoporosis Patients
prnewswire.com
MAIA
$207B Market Shift: The Race for Fast Track Approval in Oncology
prnewswire.com
AVBP
ONCY
RLAY
ZLAB
MAIA
Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment
prnewswire.com
ACRV
BNTX
IBRX
ONCY
MAIA
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
globenewswire.com
MAIA